The Pitt — Episode 2, ER scene:
"Systolic back down to 90. Another 0.1 of epi." — Dr. CollinsEpinephrine, commonly known as adrenaline, is the pharmacological cornerstone in the management of cardiopulmonary arrests and profound shock states. In the intense scenes of The Pitt, we observe its critical use both in bolus "push doses" to sustain the blood pressure of a multi-trauma patient, and in full doses (amps) during cardiopulmonary resuscitation (CPR) maneuvers for a patient in asystole.
"Resume compressions, amp of epi." — Dr. Robby
What is Epinephrine (Adrenaline)?
Epinephrine is an endogenous catecholamine, a hormone and neurotransmitter produced by the adrenal glands, which acts as a potent non-selective agonist of alpha and beta-adrenergic receptors. Synthesized for medical use, it is a fundamental sympathomimetic medication that triggers the body's classic "fight or flight" response. Its pharmacological action is complex and dose-dependent. Stimulation of alpha-1 adrenergic receptors causes intense peripheral vasoconstriction, increasing systemic vascular resistance and, consequently, blood pressure. Activation of beta-1 receptors in the heart increases inotropy (force of contraction) and chronotropy (heart rate). Meanwhile, stimulation of beta-2 receptors in the lungs promotes the relaxation of bronchial smooth muscle, resulting in profound bronchodilation. This combination of effects makes epinephrine indispensable in emergencies where tissue perfusion is critically compromised.Causes & Clinical Context
The use of epinephrine in emergency medicine covers a spectrum of immediately life-threatening conditions. The most universally recognized indication is cardiopulmonary arrest (CPA), regardless of the rhythm (ventricular fibrillation, pulseless ventricular tachycardia, pulseless electrical activity, or asystole). In CPA, the primary goal of epinephrine is alpha-adrenergic vasoconstriction, which increases diastolic aortic perfusion pressure, crucial for restoring coronary and cerebral blood flow during chest compressions. Beyond cardiac arrest, epinephrine is the first-line treatment for anaphylaxis, a rapid and severe systemic allergic reaction. It reverses the cardiovascular collapse and bronchospasm associated with massive histamine release. Epinephrine is also used as a continuous infusion or in "push doses" (small bolus doses) for the management of distributive shock (such as septic or neurogenic shock), cardiogenic shock, and symptomatic bradycardia refractory to other therapies.Signs & Symptoms
The decision to administer epinephrine is based on the identification of clinical signs of impending or established cardiovascular failure. In cardiac arrest, the patient presents an absence of a palpable central pulse, apnea or agonal breathing, and profound unconsciousness. On the cardiac monitor, rhythms such as asystole (flatline) require the immediate administration of the drug. In the context of anaphylaxis, signs include disseminated urticaria (hives), angioedema (swelling of the lips, tongue, or face), laryngeal stridor, diffuse wheezing, severe respiratory distress, tachycardia, and profound hypotension (anaphylactic shock). In non-anaphylactic shock states, the indication for vasopressor support with epinephrine arises when there is persistent hypotension (systolic blood pressure often below 90 mmHg or mean arterial pressure less than 65 mmHg) accompanied by signs of tissue hypoperfusion, such as altered mental status, oliguria (low urine output), and cold, mottled extremities, despite adequate fluid resuscitation.Diagnosis
The diagnosis preceding the use of epinephrine is primarily clinical and dynamic, requiring recognition and action in seconds. In cardiac arrest, the diagnosis is made by the rapid verification of pulselessness and apnea, followed by rhythm analysis on the defibrillator or cardiac monitor. Asystole and pulseless electrical activity (PEA) are the non-shockable rhythms where epinephrine is the main pharmacological intervention, as seen in the patient in The Pitt. In anaphylaxis, the diagnosis is clinical, based on exposure to a known (or suspected) allergen followed by the rapid development of cutaneous, respiratory, and cardiovascular symptoms. For shock, continuous hemodynamic monitoring, including blood pressure measurement (preferably invasive via an arterial line), continuous electrocardiogram, and pulse oximetry, is essential. Laboratory tests, such as serum lactate, arterial blood gases, and renal function, help assess the severity of the shock and the response to epinephrine therapy, although drug administration should never be delayed waiting for lab results.Emergency Treatment
The dosage and route of administration of epinephrine vary drastically depending on the clinical indication. In adult cardiopulmonary arrest, the standard dose is 1 mg (10 ml of a 1:10,000 solution) administered intravenously (IV) or intraosseously (IO) every 3 to 5 minutes during CPR maneuvers. In non-shockable rhythms (asystole/PEA), it should be administered as early as possible. In shockable rhythms (VF/pVT), it is administered after the second defibrillatory shock. For anaphylaxis, the preferred route is intramuscular (IM), typically in the vastus lateralis of the thigh. The adult dose is 0.3 to 0.5 mg (0.3 to 0.5 ml of a 1:1,000 solution), which can be repeated every 5 to 15 minutes if there is no clinical improvement. In the management of shock and severe hypotension, like the 0.1 mg "push dose" mentioned in the episode for the trauma patient, epinephrine is diluted and administered in small boluses or through a carefully titrated continuous infusion (e.g., 2 to 10 mcg/min) to achieve a target mean arterial pressure. To complement trauma resuscitation, fluid management is vital; see our article on Normal Saline.Prognosis & Complications
The prognosis associated with the use of epinephrine largely depends on the underlying condition and the speed of intervention. In anaphylaxis, the early administration of IM epinephrine is curative and results in an excellent prognosis. In cardiac arrest, although epinephrine increases the rate of return of spontaneous circulation (ROSC), the long-term impact on neurologically intact survival remains a subject of ongoing debate in the medical community, with some evidence suggesting that extreme vasoconstriction may impair cerebral microcirculation. The complications of epinephrine stem from its potent adrenergic stimulation. They include severe tachycardia, potentially fatal ventricular arrhythmias, myocardial ischemia (due to increased oxygen demand by the heart), severe hypertension (which can precipitate intracranial hemorrhage), extreme anxiety, tremors, and peripheral ischemia (especially in the extremities or splanchnic beds) due to prolonged vasoconstriction. Extravasation (infiltration) of IV epinephrine into surrounding tissues can cause severe tissue necrosis, requiring immediate treatment with local phentolamine. Continuous cardiac monitoring, as discussed in our post on Cardiac Arrest, is mandatory during infusion.
Frequently Asked Questions
Can epinephrine "restart" a heart that has completely stopped?
Epinephrine does not "restart" the heart electrically (that is done by the defibrillator in shockable rhythms). Instead, in asystole, it causes intense vasoconstriction that forces blood back into the coronary arteries, which can help restore the electrical activity and contractility of the heart muscle.What is the difference between epinephrine 1:1,000 and 1:10,000?
The difference is the concentration. The 1:1,000 solution (1 mg/ml) is highly concentrated and used primarily for intramuscular injection in cases of anaphylaxis. The 1:10,000 solution (0.1 mg/ml) is more dilute and used for direct intravenous injection (bolus) during cardiac arrest.What are the side effects after taking an EpiPen for allergies?
After using an EpiPen (intramuscular epinephrine), it is common to experience tachycardia (racing heart), tremors, pallor, intense anxiety, sweating, and headache. These effects are temporary and result from the surge of adrenaline in the system.Is epinephrine used in asthma attacks?
Although it is a potent bronchodilator, epinephrine is not the first-line treatment for acute asthma due to its strong cardiovascular effects. Selective beta-2 bronchodilators (like albuterol) are preferred. However, IM epinephrine can be used in severe, life-threatening refractory asthma (status asthmaticus).Conclusion
Epinephrine remains one of the most vital and versatile pharmacological agents in emergency medicine. Whether reversing the collapse of anaphylaxis or fighting to restore circulation during a cardiac arrest, its immediate impact on the cardiovascular system is unmatched. Mastery of its indications, concentrations, and administration routes is a fundamental skill for any frontline healthcare professional. To understand more about the resuscitation context, visit our detailed article on Cardiac Arrest Response in the Emergency Scenarios category.This content is for educational and informational purposes only. It does not replace professional medical advice, diagnosis, or treatment. In case of a medical emergency, call 911/EMS immediately or go to the nearest emergency room.
References: [1] AHA: CPR & ECC Guidelines [2] UpToDate: Anaphylaxis emergency treatment [3] PubMed: Epinephrine in Cardiac Arrest [4] ACEP: Anaphylaxis Management
